The Clinical Indications for Mifepristone Go Beyond Abortion

This Viewpoint discusses the broader medical value of mifepristone beyond abortion and the threat to patient safety for a variety of obstetric and gynecologic procedures that may be introduced by banning the medication.

Authors

Jessica Chen (ORCID: https://orcid.org/0009-0006-4700-1627)

Institutions

University of Pennsylvania (US)
Philadelphia University (US)

Publication Details

Journal: JAMA
Published: 2025-08-28
DOI: https://doi.org/10.1001/jama.2025.13376
Primary Topic: Opioid Use Disorder Treatment
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

The Clinical Indications for Mifepristone Go Beyond Abortion

Jessica Chen

Aug 28, 2025

JAMA

Opioid Use Disorder Treatment

article

The Clinical Indications for Mifepristone Go Beyond Abortion

Jessica Chen

August 28, 2025article en

Abstract

JAMAVol. 334(12)

University of Pennsylvania (US), Philadelphia University (US)

Openalex Percentile: Top 69%

Opioid Use Disorder Treatment

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The Clinical Indications for Mifepristone Go Beyond Abortion — Jessica Chen · JAMA (2025) | TGRS Research Map | TGRS